An Interview by Bruce Hershfield, M.D.
[Winter 2003; Vol. 29, No. 2; Pg 5, 9]

Dr. Brandt is an MPS Assembly Representative to the APA and Chair of the Department of Psychiatry at St. Joseph Hospital.
This interview was conducted on November 8, 2002
Question: Please tell
us about your work at St. Joseph's.
Answer: (Dr.
Brandt): I've been at St. Joseph now since 1996-- 6 years. I'm doing primarily
clinical work, still spending a lot of time seeing patients, doing
psychotherapy, medication management, directing the over-all programs at St.
Joe's, also spending a fair amount of time doing research. We finished a pilot
project with a Swiss foundation on the genetics of eating disorders and we
followed that with a proposal to NIH with 10 other groups to do a continuous
study of the genetics of anorexia.
Question: What led you
to become an expert on eating disorders?
Dr. Brandt: My
work in eating disorders actually started when I became a Fellow at the National
Institute of Health. That was purely by serendipity. Robert Post, who is a
leader in the treatment of mood disorders, came to Spring Grove when I was a
Resident and he gave a talk. I was interested and I went up to him and asked him
if I could come do an elective during my senior year of Residency . About 6
months later I got a letter from NIH that somebody had taken a position
elsewhere and that they were looking for somebody to come do a Fellowship there.
We were able to work it out for me to finish my Residency at NIH while pursuing
the Fellowship and it turned out that I was placed on the Eating Disorder Unit.
Question: How has the
area changed since you first began working in this field?
Dr. Brandt: It has changed dramatically, both in terms of identification of
better ways to treat patients and in terms of how it has been affected by
special forces in health care, with diminishing lengths of stay on inpatient
units. It has also been affected by the social forces that emphasize the feeling
that people need to be thin to be considered successful and attractive.
Question: What kinds
of treatment settings do you use?
Dr. Brandt: I've seen that change dramatically.
In 1990, when I moved from NIH to Mercy Hospital in Baltimore, the average
length of stay for anorexia was about 40 to 50 days and our current length of
stay on the St. Joseph inpatient unit is under 10 days. We've been forced to
develop new ways to treat patients for longer periods of time , but not on an
inpatient basis. We've developed partial hospitalization programs and intensive
outpatient programs, so the over-all length of stay has not changed nearly as
dramatically.
Question: Have you
been able to get cooperation from third party payers when you explain the needs
of these patients?
Dr. Brandt:
We've worked at that. We've tried to help insurers understand the nature of our
treatment and how in the long-term it will end up saving them money to allow us
to apply a treatment that really leads to some behavioral and cognitive change
for the patient, as opposed to the revolving door model of care that we saw
developing a number of years ago.
Question: What
programs were already in place in Baltimore when you arrived and how have you
been able to build on that?
Dr. Brandt:
Baltimore has a history of treating eating disorder patients. Arnold Andersen
was at Hopkins and really was a pioneer in the inpatient treatment of patients
with eating disorders and Angela Guarda has followed up on his work at Hopkins.
Still, we found that there was a place for our type of multidimensional
treatment at Mercy. The program at Mercy grew over the 6 years that we were
there and then in 1996 the opportunity came up for me to move to St. Joe's and
to take over as Head of Psychiatry. Also, St. Joe's basically built us a
state-of-the-art unit to continue the program.
Question: You do some
teaching, too?
Dr. Brandt:
Yes, since about 1990 I've been teaching the medical student track at University
in eating disorders and the Residency segments on eating disorders, and
supervising Residents. We also have an affiliation with University for training
where medical students and Residents rotate through our unit at St. Joe's.
Question: I understand
that you've also been doing research on the genetics of eating disorders.
Dr. Brandt:
Genetics is our current project. We've done some other projects as well through
the years. We're currently doing a placebo-controlled study of olanzapine and
fluoxetine in the treatment of anorexia. But the genetics work is our primary
focus right now. We're really excited about that because genetics research not
only helps identify genetic defects and potentially new treatments, but it also
helps to reduce the stigma about mental illness.
Question: The
description of anorexia has been around since about 1870, hasn't it?
Dr. Brandt: The
earliest description of a patient who probably had anorexia nervosa was in 1689.
There were more modern descriptions in the 1800's. Bulimia as an illness was
described also in that era, but was not identified as a modern illness until
1979 by Gerald Russell.
Question: Tell us
about the CME program at St. Joseph's.
Dr. Brandt:
That program long predated me at St. Joe's. Each November we invite a series of
speakers with some theme for a symposium. Additionally, program about eating
disorders.
Question: You must
have opportunities to work with other leaders in the field.
Dr. Brandt: I
do. Something that was exciting for me this past year was that I was on an NIH
Consensus Panel to try to figure out directions for both treatment and research
in eating disorders. It was an opportunity to interact with a number of experts
on eating disorders. Because anorexia nervosa is a relatively rare illness in
terms of the population at large (though it affects certain populations at a
higher rate, like high school and college-age women), there's a real need for
multi-center, collaborative studies. That way, we can get a large-enough group
of patients to really understand certain things, to have a high-enough power
statistically to figure out certain questions that have been around for a long
time.
Question: How did you
get involved with the MPS and how do you like being a Representative to the
Assembly?
Dr. Brandt:
I've greatly enjoyed my involvement in the MPS, first at the local level, where
I was able to rise through the Council and the officership track. I'm not a
person who likes to sit on the sidelines and watch what's going on. I've gotten
some sense of having some potential role in affecting what's happening to
psychiatry. Patients, and myself. I enjoyed that and then, at a time that I was
completing my stay in the officership track, I made the decision to move to the
Assembly. It's actually been quite an education to see how the Assembly works
and to meet people from around the country who are grappling with many of the
same issues we're grappling with in Maryland.
Question: I know that
you are married to a psychiatrist and that Joanna has been very helpful to the
MPS. What is it like to have two psychiatrists in the family?
Dr. Brandt: It
has worked well for Joanna and me. I won't say we never talk shop at home, but
we each have our core areas of interest. Joanna is a forensic psychiatrist and
has been very helpful to me when I've been involved in forensic cases.
Psychiatry is an interest that we share. We try to treat our kids as kids, as
opposed to letting our psychiatric background impinge, but some aspects of being
a parent have helped a lot in psychiatry and some aspects of psychiatry in
parenting.
Question: What
thoughts do you have about the future?
Dr. Brandt: I'm optimistic. There have been some trends in psychiatry
that have been concerning, like the diminishing use of psychotherapy and
psychodynamic concepts in psychiatry, but I've found that in my own career, at
least, that I've been able to integrate the areas of psychiatry that have been
very interesting to me. I think that there are some reasons to be optimistic
about the future of psychiatry right now. Clearly, the impact of managed care
has been difficult, but we may emerge stronger as a result, if we can figure out
ways to effectively provide care and to help people understand the important
nature of what we do.
Dr. Hershfield is the Area 3 Deputy Representative to the APA.